Our Speakers

Doreen is an Associate Professor with NUS Department of Pharmacy and Pharmaceutical Sciences and Cardiology Specialist Pharmacist practicing at the National University Heart Center, Singapore. She previously headed Khoo Teck Puat Hospital Pharmacy Department, crossed to Corporate Development as Assistant Director of Value Office before joining National University of Singapore Department of Pharmacy fulltime. She continues to lobby for rational use of cardiovascular pharmacotherapy and the value of CV team pharmacists in her role as Board member of the International Society of Cardiovascular Pharmacotherapy (ISCP) through the founding of the A to Z of CV Pharmacotherapy webinar series and the ISCP CLAPs (CataLysing ReAl-World Cardiovascular Pharmacotherapy).

 

Active with practice and precision medicine research, she wrote the grant for the implementation of individualisation of antiplatelets using CYP2C19 in clinical practice, fondly called “iRight4Me Antiplatelet Therapy”, which enrolled its 1007th patient in Feb 2024 before its conclusion. She is an appointed member of the National University Health System’s Steering Committee for Pharmacogenomics. As part of her role the workgroup of education and training in the Steering Committee, she proactively wove cardiology-related Pharmacogenomics into the Undergraduate and Doctor of Pharmacy curriculum. Doreen is co-investigator for Precision Health Research’s Clinical Implementation Pilot (PRECISE CIP: https://www.npm.sg/about-us/our-story/) and Study PI on “DTSY Statin Therapy” funded by the Ministry of Education - her most recent project on use of statin pharmacogenomics which has commenced recruitment at the National University Polyclinics (NUP) in April 2024.

 

Doreen is also an enthusiast for translational research and digital health interventions. She is the pharmacist lead for the national pragmatic study AMI-HOPE (Acute Myocardial Infarction allied Health-Oriented Patient-centered digitally-Enabled care), a Ministry of Health-funded Health Services Development Programme (HSDP), a digital-based post-myocardial infarction care program delivered by specialty-trained collaborative prescriber Pharmacists. Her other study, AdLip: Use of human-AI Symbiosis Personal Health Assistant to improve Adherence to Lipid-Lowering medications under CADENCE: https://www.cadence-cvd.sg/ which has commenced June 2024. She has authored papers in the subject area of cardiovascular medicine and pharmacogenomics.

Assoc Prof Doreen Tan's Session:

• Pharmacy Symposium 1
  Date: 20 Sep 2025, Saturday | Time: 1115—1245 | Venue: Level 1, L1-S3